151 related articles for article (PubMed ID: 32611506)
1. High-Scatter Lymphocytes in the Blood of Erythrodermic Cutaneous T-Cell Lymphoma: Evidence for Large-Cell Transformation?
Vonderheid EC; Jakubowski J; Hou JS
Clin Lymphoma Myeloma Leuk; 2020 Sep; 20(9):624-631.e2. PubMed ID: 32611506
[TBL] [Abstract][Full Text] [Related]
2. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
[TBL] [Abstract][Full Text] [Related]
3. Histopathologic studies in Sézary syndrome and erythrodermic mycosis fungoides: a comparison with benign forms of erythroderma.
Sentis HJ; Willemze R; Scheffer E
J Am Acad Dermatol; 1986 Dec; 15(6):1217-26. PubMed ID: 2948972
[TBL] [Abstract][Full Text] [Related]
4. The MicroRNA Expression Profile Differs Between Erythrodermic Mycosis Fungoides and Sézary Syndrome.
Rittig AH; Lindahl LM; Johansen C; Celis P; Ødum N; Iversen L; Litman T
Acta Derm Venereol; 2019 Nov; 99(12):1148-1153. PubMed ID: 31453630
[TBL] [Abstract][Full Text] [Related]
5. Blood classification and blood response criteria in mycosis fungoides and Sézary syndrome using flow cytometry: recommendations from the EORTC cutaneous lymphoma task force.
Scarisbrick JJ; Hodak E; Bagot M; Stranzenbach R; Stadler R; Ortiz-Romero PL; Papadavid E; Evison F; Knobler R; Quaglino P; Vermeer MH
Eur J Cancer; 2018 Apr; 93():47-56. PubMed ID: 29477101
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis, prognosis and management of erythrodermic cutaneous T-cell lymphoma.
Moriarty B; Whittaker S
Expert Rev Hematol; 2015 Apr; 8(2):159-71. PubMed ID: 25495961
[TBL] [Abstract][Full Text] [Related]
7. CD4
Vonderheid EC; Hou JS
Leuk Lymphoma; 2018 Feb; 59(2):330-339. PubMed ID: 28595473
[TBL] [Abstract][Full Text] [Related]
8. The relevance of peripheral blood T-helper 1 and 2 cytokine pattern in the evaluation of patients with mycosis fungoides and Sézary syndrome.
Papadavid E; Economidou J; Psarra A; Kapsimali V; Mantzana V; Antoniou C; Limas K; Stratigos A; Stavrianeas N; Avgerinou G; Katsambas A
Br J Dermatol; 2003 Apr; 148(4):709-18. PubMed ID: 12752128
[TBL] [Abstract][Full Text] [Related]
9. A histo-immunopathologic and prognostic study of erythrodermic cutaneous T-cell lymphoma.
Vonderheid EC; Kantor GR; Telang GH; Bujanouskas P; Kadin ME
J Cutan Pathol; 2019 Dec; 46(12):913-924. PubMed ID: 31403211
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of tumor burden in the blood of patients with erythrodermic primary cutaneous T-cell lymphoma.
Scarisbrick JJ; Whittaker S; Evans AV; Fraser-Andrews EA; Child FJ; Dean A; Russell-Jones R
Blood; 2001 Feb; 97(3):624-30. PubMed ID: 11157477
[TBL] [Abstract][Full Text] [Related]
11. Overall survival in erythrodermic cutaneous T-cell lymphoma: an analysis of prognostic factors in a cohort of patients with erythrodermic cutaneous T-cell lymphoma.
Vidulich KA; Talpur R; Bassett RL; Duvic M
Int J Dermatol; 2009 Mar; 48(3):243-52. PubMed ID: 19261011
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Significance of Serum Copper in Patients With Cutaneous T-cell Lymphoma.
Vonderheid EC; Martinez AR
Clin Lymphoma Myeloma Leuk; 2019 Apr; 19(4):228-238.e4. PubMed ID: 30745139
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous histopathology of Sézary syndrome: a study of 41 cases with a proven circulating T-cell clone.
Trotter MJ; Whittaker SJ; Orchard GE; Smith NP
J Cutan Pathol; 1997 May; 24(5):286-91. PubMed ID: 9194581
[TBL] [Abstract][Full Text] [Related]
14. Biophysical characterization of normal T-lymphocytes and Sézary cells.
Vonderheid EC; Fang SM; Helfrich MK; Abraham SR; Nicolini CA
J Invest Dermatol; 1981 Jan; 76(1):28-37. PubMed ID: 6970232
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal T-cell dyscrasia of undetermined significance associated with recalcitrant erythroderma.
Gniadecki R; Lukowsky A
Arch Dermatol; 2005 Mar; 141(3):361-7. PubMed ID: 15781677
[TBL] [Abstract][Full Text] [Related]
16. Comment on B ratings for erythrodermic cutaneous T-cell lymphoma.
Vonderheid E
Eur J Cancer; 2018 Sep; 101():281-283. PubMed ID: 30017384
[No Abstract] [Full Text] [Related]
17. T-cell receptor gene rearrangement analysis: cutaneous T cell lymphoma, peripheral T cell lymphoma, and premalignant and benign cutaneous lymphoproliferative disorders.
Zelickson BD; Peters MS; Muller SA; Thibodeau SN; Lust JA; Quam LM; Pittelkow MR
J Am Acad Dermatol; 1991 Nov; 25(5 Pt 1):787-96. PubMed ID: 1839392
[TBL] [Abstract][Full Text] [Related]
18. Circulating CD4+CD7- lymphocyte burden and rapidity of response: predictors of outcome in the treatment of Sézary syndrome and erythrodermic mycosis fungoides with extracorporeal photopheresis.
Stevens SR; Baron ED; Masten S; Cooper KD
Arch Dermatol; 2002 Oct; 138(10):1347-50. PubMed ID: 12374541
[TBL] [Abstract][Full Text] [Related]
19. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors in erythrodermic mycosis fungoides and the Sézary syndrome.
Kim YH; Bishop K; Varghese A; Hoppe RT
Arch Dermatol; 1995 Sep; 131(9):1003-8. PubMed ID: 7661601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]